» BioInvent deepens collaboration with MSD
» Prolight's COO comments on the collaboration with FlexMedical Solutions
» Chordate comments on the Q4 report and case description
» Lipum seeks patent for inflammation-induced cancer
» Synact focuses on driving the RA project forward
Read BioStock's weekly newsletter for v.13 here.
Latest news of the day
The last patient has been recruited in Infant Bacterial Therapeutics Phase III study. Read more.
CS MEDICA receives regulatory approval from CANNASEN Protective Nasal Gel in Malaysia. Read more.
Carbiotix begins NutraCycle-pilot study with leading American food and beverage manufacturer. Read more.
OncoZenge obtains positive stability data for BupiZenge. Read more.
Magle Chemoswed Holding publishes offer document and announces updated timetable regarding the cash offer to the shareholders of Amniotic. Read more.
Vimian Group The rights issue was subscribed to approximately 137 percent. Read more.
RaySearch presents the latest innovations in RayStation, RayCare and RayIntelligence on ISOP and NPC. Read more.
Dicot announces that reporting from part of the phase I study will be at the end of April. Read more.
AstraZeneca Imfinzi significantly improved overall survival and progression-free survival for patients with small cell lung cancer in limited disease in the phase III ADRIATIC study. Read more.
SensoDetect informs that it is continuing its commercial journey in Saudi Arabia. Read more.
AcouBlack sees a growing interest in AcouTrap EV isolation for nanoflow cytometry. Read more.
Dignity announces that the company's rights issue of SEK 19,1 million has been fully subscribed. Read more.
Today marks the start of the utilization period for Prostatype Genomics Series 3 warrants. Read more.
Qlife announces that it has placed its Danish operating company in receivership as a temporary measure. Read more.
VitroLife Group invites you to a telephone conference in connection with the Q1 report. Read more.
NeoDynamics announces final outcome regarding rights of use of series TO3. Read more.
Photocure will participate in 23rd Annual Needham Virtual Healthcare Conference. Read more.
Last day for trading with Nanologicas BTA is April 8th. Read more.
The Nomination Committee for Ortivus proposes a new chairman of the board. Read more.
Annual Reports
Arcoma BioInvent Bio Vitos Pharma Medivir Stille By having XVIVO Perfusion
Upcoming presentations
Summons
Alligator Bioscience Boule Diagnostics InDex Pharmaceuticals Medivir Modulight Ortivus Vitrolife Group QuiaPEG Pharmaceuticals
Communiqués
Gubra Miris Holding Revenio Group
This morning's price development
Index: OMXS30 -1,2% Healthcare -1,0%
| Winner | Förlorare |
| AlzeCure Pharma 22,1% | Qlife Holding -55,1% |
| Respiratory 20,2% | SoftOx Solutions -47,2% |
| CS Medica 17,2% | Raytelligence -40,0% |
| PharmaLundensis 12,3% | QuiaPEG -11,9% |
| S2Medical 11,1% | PILA PHARMA -9,3% |